Price T Rowe Associates Inc Rigel Pharmaceuticals Inc Transaction History

Price T Rowe Associates Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.12 - $1.57 $10,212 - $14,315	9,118 Added 8.77%	113,047 $168,000
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.56 $2,651 - $5,745	3,683 Added 3.67%	103,929 $151,000
Q3 2023 Nov 14, 2023	BUY	$1.07 - $1.39 $1,468 - $1,907	1,372 Added 1.39%	100,246 $109,000
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.82 $15,620 - $25,383	-13,947 Reduced 12.36%	98,874 $128,000
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $5,135 - $8,216	4,108 Added 3.78%	112,821 $149,000
Q3 2022 Nov 14, 2022	SELL	$1.1 - $12.2 $65,547 - $726,985	-59,589 Reduced 35.41%	108,713 $129,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $57,084 - $271,788	85,200 Added 102.52%	168,302 $190,000
Q1 2022 May 16, 2022	BUY	$2.22 - $3.45 $63,594 - $98,828	28,646 Added 52.6%	83,102 $248,000
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $8,260 - $12,495	-3,500 Reduced 6.04%	54,456 $144,000
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $3,881 - $4,990	1,109 Added 1.95%	57,956 $210,000
Q2 2021 Aug 16, 2021	BUY	$3.09 - $4.54 $39,845 - $58,543	12,895 Added 29.34%	56,847 $247,000
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $108,339 - $159,436	32,340 Added 278.5%	43,952 $150,000
Q4 2020 Feb 16, 2021	BUY	$2.35 - $3.74 $27,288 - $43,428	11,612 New	11,612 $41,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.